Radioligand therapy of pancreatic ductal adenocarcinoma using an αvβ6-integrin targeting 68Ga / 177Lu labeled theranostic pair
European Journal of Nuclear Medicine and Molecular Imaging · 2026-06 · 53 (7) · 4304-4306
DOI: 10.1007/s00259-025-07701-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 08.12.2025. Verfasst von Jan Wuestemann und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nuclear Medicine, Department of Radiology and Nuclear Medicine, University Hospital Magdeburg, Leipziger Straße 44, 39120, Magdeburg, Ger…. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 6 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Technische Universität München.
Abstract (Originalsprache)
αvβ6-integrin targeted pretherapeu - tic PET/CT (A, maximum intensity projection (MIP); B, axial fusion; acquired 90 min after injection of 141 MBq of 68 Ga-D0103) [ 5 ], as well as intratherapeutic SPECT/ CT (C, E, MIP; D, F, axial fusion) of a male patient with metastatic carcinoma of the pancreatic head (60 y, 66 kg; progressive with liver metastasis, 21 months after pylorus-preserving pancreatic head resection with radical lymph node dissection, adjuvant folfirinox, gemcitabine + 5-fluo - rouracil
Autor:innen und Institutionen
- Division of Nuclear Medicine, Department of Radiology and Nuclear Medicine, University Hospital Magdeburg, Leipziger Straße 44, 39120, Magdeburg, Germany.
- TRIMT GmbH, Carl-Eschebach-Str. 7, 01454, Radeberg, Germany.
- Department of Radiology, Wake Forest School of Medicine, Winston Salem, NC, USA.
- Department of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman, Jordan.
- School of Medicine, University of Jordan, Amman, Jordan.
- TRIMT GmbH, Carl-Eschebach-Str. 7, 01454, Radeberg, Germany. tum@notni.de.
Förderung
- Technische Universität München
Zitieren
APA
Wuestemann, J., Eppard, E., Hescheler, D., Wybranska, J., Kupitz, D., Reissig, F., Almaguel, F. G., Al-Ibraheem, A., Notni, J., & Kreissl, M. C. (2026). Radioligand therapy of pancreatic ductal adenocarcinoma using an αvβ6-integrin targeting 68Ga / 177Lu labeled theranostic pair. European Journal of Nuclear Medicine and Molecular Imaging, 53(7), 4304-4306. https://doi.org/10.1007/s00259-025-07701-5
Vancouver
Wuestemann J, Eppard E, Hescheler D, Wybranska J, Kupitz D, Reissig F, et al. Radioligand therapy of pancreatic ductal adenocarcinoma using an αvβ6-integrin targeting 68Ga / 177Lu labeled theranostic pair. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(7):4304-4306. doi:10.1007/s00259-025-07701-5
BibTeX
@article{Wuestemann2026,
author = {Wuestemann, Jan and Eppard, Elisabeth and Hescheler, Daniel and Wybranska, Joanna and Kupitz, Dennis and Reissig, Falco and Almaguel, Frankis G and Al-Ibraheem, Akram and Notni, Johannes and Kreissl, Michael C},
title = {Radioligand therapy of pancreatic ductal adenocarcinoma using an αvβ6-integrin targeting 68Ga / 177Lu labeled theranostic pair},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
volume = {53},
number = {7},
pages = {4304--4306},
doi = {10.1007/s00259-025-07701-5}
}
EUVIMED